NEA Management Company, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$1.3T
Holdings
32
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (32 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACLXARCELLX INC | 3,745,262 | $246.6B | 18.56% | |
| 2 | VRNAVERONA PHARMA PLC | 2,263,138 | $214.0B | 16.11% | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | 2,909,956 | $183.9B | 13.84% | |
| 4 | COURCOURSERA INC | 12,867,769 | $112.7B | 8.49% | |
| 5 | CRSPCRISPR THERAPEUTICS AG | 1,587,854 | $77.2B | 5.81% | |
| 6 | TRVITREVI THERAPEUTICS INC | 13,222,228 | $72.3B | 5.44% | |
| 7 | YB4PSAVARA INC | 24,471,264 | $55.8B | 4.20% | |
| 8 | ORICORIC PHARMACEUTICALS INC | 4,118,621 | $41.8B | 3.15% | |
| 9 | MBXMBX BIOSCIENCES INC | 3,614,486 | $41.2B | 3.10% | |
| 10 | GLUEMONTE ROSA THERAPEUTICS INC | 7,692,298 | $34.7B | 2.61% | |
| 11 | AUPHAURINIA PHARMACEUTICALS INC | 3,969,834 | $33.6B | 2.53% | |
| 12 | CELCCELCUITY INC | 2,294,261 | $30.6B | 2.31% | |
| 13 | ZBIOZENAS BIOPHARMA INC | 2,733,719 | $26.5B | 1.99% | |
| 14 | GOSSGOSSAMER BIO INC | 18,093,034 | $22.3B | 1.68% | |
| 15 | —NEUEHEALTH INC | 2,726,917 | $18.8B | 1.42% | |
| 16 | PHATPHATHOM PHARMACEUTICALS INC | 1,960,169 | $18.8B | 1.42% | |
| 17 | KRROKORRO BIO INC | 1,090,793 | $13.6B | 1.03% | |
| 18 | CSBRCHAMPIONS ONCOLOGY INC | 1,713,720 | $12.6B | 0.95% | |
| 19 | CVRXCVRX INC | 2,026,083 | $11.9B | 0.90% | |
| 20 | BDTXBLACK DIAMOND THERAPEUTICS I | 4,448,757 | $11.0B | 0.83% | |
| 21 | INZYINOZYME PHARMA INC | 2,437,689 | $9.8B | 0.73% | |
| 22 | SNTISENTI BIOSCIENCES INC | 3,775,615 | $8.0B | 0.60% | |
| 23 | OMDAOMADA HEALTH INC | 364,115 | $6.7B | 0.50% | |
| 24 | NKTXNKARTA INC | 3,568,781 | $5.9B | 0.45% | |
| 25 | IVAINVENTIVA SA | 1,462,586 | $4.7B | 0.35% | |
| 26 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 17,079,778 | $4.1B | 0.31% | |
| 27 | SYBXSYNLOGIC INC | 2,922,772 | $3.7B | 0.28% | |
| 28 | MRKRMARKER THERAPEUTICS INC | 1,625,678 | $2.5B | 0.19% | |
| 29 | OKURONKURE THERAPEUTICS INC | 478,548 | $1.1B | 0.09% | |
| 30 | ASNSUSDX4 PHARMACEUTICALS INC | 499,559 | $949.2M | 0.07% | |
| 31 | —IKENA ONCOLOGY INC | 600,063 | $804.1M | 0.06% | |
| 32 | UPWHEELS UP EXPERIENCE INC | 106,125 | $113.6M | 0.01% |